What is Seaport Res Ptn’s Forecast for Innospec Q4 Earnings?

Innospec Inc. (NASDAQ:IOSPFree Report) – Analysts at Seaport Res Ptn cut their Q4 2024 earnings per share estimates for Innospec in a note issued to investors on Wednesday, January 22nd. Seaport Res Ptn analyst M. Harrison now anticipates that the specialty chemicals company will post earnings of $1.36 per share for the quarter, down from their previous estimate of $1.38. The consensus estimate for Innospec’s current full-year earnings is $5.88 per share. Seaport Res Ptn also issued estimates for Innospec’s Q1 2025 earnings at $1.35 EPS, Q2 2025 earnings at $1.39 EPS, Q3 2025 earnings at $1.50 EPS, Q4 2025 earnings at $1.64 EPS, FY2025 earnings at $5.87 EPS and FY2026 earnings at $6.96 EPS.

Separately, StockNews.com cut Innospec from a “strong-buy” rating to a “buy” rating in a research note on Saturday, January 11th.

Get Our Latest Stock Report on IOSP

Innospec Price Performance

NASDAQ IOSP opened at $115.25 on Thursday. The business has a fifty day moving average price of $113.86 and a two-hundred day moving average price of $114.67. Innospec has a fifty-two week low of $103.65 and a fifty-two week high of $133.71. The stock has a market capitalization of $2.87 billion, a PE ratio of 20.11 and a beta of 1.09.

Innospec (NASDAQ:IOSPGet Free Report) last issued its quarterly earnings results on Tuesday, November 5th. The specialty chemicals company reported $1.35 earnings per share (EPS) for the quarter, meeting the consensus estimate of $1.35. Innospec had a return on equity of 13.33% and a net margin of 7.68%. The business had revenue of $443.40 million during the quarter, compared to analysts’ expectations of $442.13 million. During the same period in the previous year, the company posted $1.59 earnings per share. The firm’s revenue for the quarter was down 4.5% compared to the same quarter last year.

Innospec Increases Dividend

The business also recently declared a Semi-Annual dividend, which was paid on Tuesday, November 26th. Stockholders of record on Monday, November 18th were issued a dividend of $0.79 per share. The ex-dividend date was Monday, November 18th. This is an increase from Innospec’s previous Semi-Annual dividend of $0.72. This represents a dividend yield of 1.3%. Innospec’s dividend payout ratio is 27.57%.

Insider Transactions at Innospec

In other news, Director Milton C. Blackmore sold 1,035 shares of the firm’s stock in a transaction dated Wednesday, November 13th. The stock was sold at an average price of $122.92, for a total transaction of $127,222.20. Following the completion of the transaction, the director now directly owns 9,028 shares in the company, valued at $1,109,721.76. This trade represents a 10.29 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 1.52% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Pacer Advisors Inc. acquired a new position in shares of Innospec in the 4th quarter worth approximately $53,457,000. KBC Group NV lifted its position in shares of Innospec by 82.3% in the 4th quarter. KBC Group NV now owns 1,236 shares of the specialty chemicals company’s stock worth $136,000 after purchasing an additional 558 shares during the period. Blue Trust Inc. lifted its position in shares of Innospec by 54.2% in the 4th quarter. Blue Trust Inc. now owns 1,201 shares of the specialty chemicals company’s stock worth $136,000 after purchasing an additional 422 shares during the period. Ballentine Partners LLC lifted its position in shares of Innospec by 11.0% in the 4th quarter. Ballentine Partners LLC now owns 2,968 shares of the specialty chemicals company’s stock worth $327,000 after purchasing an additional 295 shares during the period. Finally, ZWJ Investment Counsel Inc. lifted its position in shares of Innospec by 0.6% in the 4th quarter. ZWJ Investment Counsel Inc. now owns 43,426 shares of the specialty chemicals company’s stock worth $4,779,000 after purchasing an additional 279 shares during the period. Institutional investors and hedge funds own 96.64% of the company’s stock.

About Innospec

(Get Free Report)

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.

Featured Articles

Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.